This is a preview of subscription content, log in via an institution to check access.
Reference
Pecile A. et al. Experientia 1975; 31: 332–3
References
Christiansen C, et al. Calcif Tissue Int 1991; 49 Suppl 2: S14–5
Rico H, et al. Bone Miner 1992; 16: 131–8
Overgaard K, et al. Br Med J 1992; 305: 1124–8
References
Ravn P. Clemmesen B Riis BJ, Christiansen C. The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A1-year randomized, double-blind, placebo-controlled dose finding study. Bone 1998;19:827–533.
Ravn P, Christiansen JO, Baumann M, Clemmesen B. Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment. Prediction of bone mass changes during treatment. Submitted for publication to Bone. 1997.
Rights and permissions
About this article
Cite this article
Satellite Abstracts. Osteoporosis International 8 (Suppl 3), 146–157 (1998). https://doi.org/10.1007/BF03262414
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03262414